Innovita Biological Technology Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Xiujie Zhang
Chief executive officer
CN¥1.4m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4yrs |
| CEO ownership | 9.2% |
| Management average tenure | no data |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
We Think Innovita Biological Technology's (SHSE:688253) Robust Earnings Are Conservative
Nov 01
Investors Could Be Concerned With Innovita Biological Technology's (SHSE:688253) Returns On Capital
Sep 28Statutory Profit Doesn't Reflect How Good Innovita Biological Technology's (SHSE:688253) Earnings Are
Apr 22There's Reason For Concern Over Innovita Biological Technology Co., Ltd.'s (SHSE:688253) Massive 25% Price Jump
Mar 20CEO
Xiujie Zhang (53 yo)
4yrs
Tenure
CN¥1,360,600
Compensation
Ms. Xiujie Zhang serves as Director and General Manager at Innovita Biological Technology Co., Ltd. since November 9, 2020.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 4yrs | CN¥1.36m | 9.19% CN¥ 523.4m | |
| Director | 4yrs | CN¥10.00k | no data | |
| Independent Director | 4yrs | CN¥86.70k | no data | |
| Independent Director | 4yrs | CN¥86.70k | no data | |
| Independent Director | 4yrs | CN¥86.70k | no data | |
| Chairman of the Board | 4yrs | CN¥294.40k | 27.84% CN¥ 1.6b |
4.0yrs
Average Tenure
50yo
Average Age
Experienced Board: 688253's board of directors are considered experienced (4 years average tenure).